AR and breast carcinoma: It is notable that PIP is a key target of AR that is required for cell cycle progression and acts an effector of AR function in breast cancer (Baniwal et al., 2012; Naderi, 2015b; Naderi and Meyer, 2012; Naderi and Vanneste, 2014).